mailyard(SH:600107) Zheng Quan Zhi Xing·2025-06-20 09:18Group 1 - The company plans to sell 100% equity of its subsidiary, Qinghai Zhongyou Health Huijia Pharmaceutical Chain Co., Ltd., to Jilin Zhiyu Technology Co., Ltd. for a price of 100 million RMB [1] - The company has received 70 million RMB of the equity transfer payment and has transferred 51% of the equity to Zhiyu Technology, but due to the failure of Zhiyu Technology to pay the remaining amount, the company has filed a lawsuit [2] - On June 9, 2025, Zhiyu Technology paid 20 million RMB to the court account as part of the equity transfer payment [2][3] Group 2 - Qinghai Huijia has completed the industrial and commercial change and is now a wholly-owned subsidiary of Zhiyu Technology [2] - The company has received 20 million RMB from the Huangshi City Xiaolu District People's Court [3] - Qinghai Huijia has made the first payment to the company as per the settlement agreement regarding previous borrowings [3]